Preferred Label : tivozanib;

MeSH note : structure in first source;

CISMeF synonym : AV 951; KRN 951;

MeSH hyponym : AV951 cpd; AV-951; KRN951; KRN-951;

Is substance : O;

UNII : 172030934T;

InChIKey : SPMVMDHWKHCIDT-UHFFFAOYSA-N;

Détails


Consulter ci-dessous une sélection des principales ressources :

Vous pouvez consulter :


https://www.has-sante.fr/portail/jcms/c_2884088/fr/fotivda-tivozanib-inhibiteur-de-proteine-kinase
2019
false
false
false
France
French
evaluation of the transparency committee
guidelines for drug use
tivozanib
tivozanib
receptors, vascular endothelial growth factor
antineoplastic agents
antineoplastic agents
carcinoma, renal cell
neoplasm metastasis
adult
treatment outcome
insurance, health, reimbursement
tivozanib
Tyrosine Kinase Inhibitors
phenylurea compounds
quinolines
phenylurea compounds
quinolines

---
https://www.has-sante.fr/portail/jcms/c_2884088/fr/fotivda
2018
false
false
false
France
tivozanib
tivozanib
tivozanib
administration, oral
treatment outcome
adult
carcinoma, renal cell
receptors, vascular endothelial growth factor
Tyrosine Kinase Inhibitors
evaluation of the transparency committee
phenylurea compounds
quinolines
phenylurea compounds
quinolines

---
Nous contacter.
27/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.